The Reliability of Rifampicin Resistance Identified on Xpert® MTB/RIF as a Proxy for Multidrug-Resistant Tuberculosis (MDR-TB) in a Reference Center for MDR-TB in Rio de Janeiro, Brazil

被引：0
|
作者：
Santos, A. [1 ]
Leung, J. [1 ]
Malaquias, T. [1 ]
Vieira, M. M. [2 ]
Kritski, A. [3 ]
Mello, F. C. Q. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, BR-21941913 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Rio de Janeiro, IDT, Rio de Janeiro, Brazil
[3] Univ Rio De Djaneiro, BR-20241220 Rio De Janeiro, Brazil
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5544
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MDR-TB treatment efficacy by results of Xpert MTB/RIF assayin the Stavropol region of the Russian Federation
    Komissarova, Oksana
    Abdullaev, Rizvan
    Chumakova, Yelena
    Odinets, Vasiliy
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [42] MDR-TB treatment efficacy according of conventional method and Xpert MTB/RIF results in Republic of Moldova
    Malic, Alina
    Vilc, Valentina
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [43] Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Coker, R
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (08) : 649 - 650
  • [44] Outcome of multidrug-resistant tuberculosis (MDR-TB): A comparison between inpatient and outpatient therapy.
    Alonso, P
    Narita, M
    Lausardo, M
    Hollender, E
    Ashkin, D
    Pitchenik, AE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A551 - A551
  • [45] Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
    Ateba-Ngoa, U.
    Edoa, J. R.
    Adegbite, B. R.
    Rossatanga, E. G.
    Madiou, D.
    Mfoumbi, A.
    Mevyann, C.
    Agbo, P. Achimi
    Mahoumbou, J.
    Gould, S.
    Lell, B.
    Adegnika, A. A.
    Koehler, C.
    Kremsner, P. G.
    Massinga-Loembe, M.
    Alabi, A.
    Grobusch, M. P.
    INFECTION, 2019, 47 (05) : 811 - 816
  • [46] The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
    Brigaste M.B.T.
    Teh L.A.
    Psychological Studies, 2018, 63 (1) : 9 - 18
  • [47] Acute Respiratory Failure and Sepsis Due to Multidrug-Resistant Tuberculosis (MDR-TB) in a Pregnant Midwife
    Colunche, C.
    Angeles, B.
    Maguina, M.
    Yachachin, J.
    Chavez, W.
    Diaz, J.
    Accinelli, R.
    Valdivia, E.
    Tafur, K.
    Morello, E.
    Chancafe, R.
    Cok, J.
    Lovaton, N.
    Gayoso, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] Identification of Serum Cytokine Biomarkers Associated with Multidrug Resistant Tuberculosis (MDR-TB)
    Mensah, Gloria Ivy
    Boakye, Alahaman Nana
    Basingnaa, Anthony
    Owusu, Enid
    Antwi-Baffour, Samuel
    Ofori, Michael Fokuo
    Addo, Kennedy Kwasi
    Jackson-Sillah, Dolly
    Adekambi, Toidi
    IMMUNO, 2021, 1 (04): : 400 - 409
  • [49] Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China
    Liu, Y.
    Sun, Y.
    Zhang, X.
    Zhang, Z.
    Xing, Q.
    Ren, W.
    Yao, C.
    Yu, J.
    Ding, B.
    Wang, S.
    Li, C.
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [50] Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Gupta, R
    Raviglione, MC
    Espinal, MA
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (12) : 1078 - 1079
12345